Dr. Matthias Gimpel and colleagues from the group of Prof. Peter Neubauer are developing together with the group of Prof. Roland Lauster (both TUB) and the Charité a test system to evaluate the immune status of the population against COVID-19. The scientists from the Neubauer group are also in contact with the Berlin based company Biotechrabbit to support this manufacturer with the production of enzymes that are required for their Corona test kit.
